Clinical Trials in Colorado

Showing 4741-4760 of 18,143 trials

An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

NCT05393895

This is a multi-center, double-masked, vehicle-controlled study. The purpose of the study is to evaluate the safety of CSF-1 compared with vehicle in presbyopic subjects. Subjects will be treated for at least 6 weeks.

Presbyopia

Orasis Pharmaceuticals Ltd.178 participantsStarted Apr 2022

Newport Beach, California, United States • Petaluma, California, United States • Colorado Springs, Colorado, United States +9 more locations

Active Not RecruitingNA41 miles

Reproductive Health Program in Patients With Cancer

NCT01806129

This clinical trial studies reproductive health program in patients with cancer. A reproductive health program may improve patients' understanding of reproductive risks and receipt of appropriate treatment to achieve their reproductive health goals.

Malignant Neoplasm

ECOG-ACRIN Cancer Research Group434 participantsStarted Sep 2016

Jonesboro, Arkansas, United States • Aurora, Colorado, United States • Boulder, Colorado, United States +106 more locations

An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

Reproductive Health Program in Patients With Cancer

Find Trials by Condition in Colorado

A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer

A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic

Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

Microfragmented Adipose Tissue Compared to Saline Injection for the Treatment of Knee Osteoarthritis

A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region

A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis

Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy

A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

Shared-Decision Making for Hydroxyurea

A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes